281 related articles for article (PubMed ID: 31671060)
1. Plaque Sealing With Drug-Eluting Stents Versus Medical Therapy for Treating Intermediate Non-Obstructive Saphenous Vein Graft Lesions: A Pooled Analysis of the VELETI and VELETI II Trials.
Maes F; Jolly SS; Cairns J; Delarochellière R; Côté M; Dzavik V; Rodés-Cabau J
J Invasive Cardiol; 2019 Nov; 31(11):E308-E315. PubMed ID: 31671060
[TBL] [Abstract][Full Text] [Related]
2. Sealing Intermediate Nonobstructive Coronary Saphenous Vein Graft Lesions With Drug-Eluting Stents as a New Approach to Reducing Cardiac Events: A Randomized Controlled Trial.
Rodés-Cabau J; Jolly SS; Cairns J; Mansour S; L'Allier PL; Teefy PJ; Graham JJ; Le May MR; Cantor WJ; Wood D; Balasubramanian K; DeLarochellière R; Dzavik V;
Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27815344
[TBL] [Abstract][Full Text] [Related]
3. Five-year follow-up of the plaque sealing with paclitaxel-eluting stents vs medical therapy for the treatment of intermediate nonobstructive saphenous vein graft lesions (VELETI) trial.
Rodés-Cabau J; Bertrand OF; Larose E; Déry JP; Rinfret S; Urena M; Jerez M; Nombela-Franco L; Ribeiro HB; Allende R; Proulx G; Nguyen CM; Boudreault JR; Rouleau J; Roy L; Gleeton O; Barbeau G; Noël B; Côté M; Després JP; Dagenais GR; DeLarochellière R
Can J Cardiol; 2014 Jan; 30(1):138-45. PubMed ID: 24365196
[TBL] [Abstract][Full Text] [Related]
4. Drug eluting versus bare metal stents for percutaneous coronary intervention of saphenous vein graft lesions: An updated meta-analysis of randomized controlled trials.
Ha FJ; Nogic J; Montone RA; Cameron JD; Nerlekar N; Brown AJ
Cardiovasc Revasc Med; 2018; 19(7 Pt B):837-844. PubMed ID: 29685385
[TBL] [Abstract][Full Text] [Related]
5. Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials.
Bhogal S; Panchal HB; Bagai J; Banerjee S; Brilakis ES; Mukherjee D; Kumar G; Shanmugasundaram M; Paul TK
Cardiovasc Revasc Med; 2019 Sep; 20(9):758-767. PubMed ID: 30503811
[TBL] [Abstract][Full Text] [Related]
6. Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions: the moderate vein graft lesion stenting with the taxus stent and intravascular ultrasound (VELETI) pilot trial.
Rodés-Cabau J; Bertrand OF; Larose E; Déry JP; Rinfret S; Bagur R; Proulx G; Nguyen CM; Côté M; Landcop MC; Boudreault JR; Rouleau J; Roy L; Gleeton O; Barbeau G; Noël B; Courtis J; Dagenais GR; Després JP; DeLarochellière R
Circulation; 2009 Nov; 120(20):1978-86. PubMed ID: 19884468
[TBL] [Abstract][Full Text] [Related]
7. The short- and long-term outcomes of percutaneous intervention with drug-eluting stent vs bare-metal stent in saphenous vein graft disease: An updated meta-analysis of all randomized clinical trials.
Kheiri B; Osman M; Abdalla A; Ahmed S; Bachuwa G; Hassan M
Clin Cardiol; 2018 May; 41(5):685-692. PubMed ID: 29749621
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes with first- vs. second-generation drug-eluting stents in saphenous vein graft lesions.
Pokala NR; Menon RV; Patel SM; Christopoulos G; Christakopoulos GE; Kotsia AP; Rangan BV; Roesle M; Abdullah S; Grodin J; Kumbhani DJ; Hastings J; Banerjee S; Brilakis ES
Catheter Cardiovasc Interv; 2016 Jan; 87(1):34-40. PubMed ID: 26033073
[TBL] [Abstract][Full Text] [Related]
9. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing saphenous vein graft intervention with drug-eluting stents: a multicenter Southern Californian Registry.
Lee MS; Hu PP; Aragon J; Shah A; Bhatia R; Jones N; Penny W; French W; Tobis J; Mahmud E
Catheter Cardiovasc Interv; 2010 Aug; 76(2):272-8. PubMed ID: 20623716
[TBL] [Abstract][Full Text] [Related]
10. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
Tolerico PH; Cohen DJ; Kleiman NS; Berger PB; Brilakis ES; Piana RN; Shammo S; Keyes MJ; Kennedy KF; Massaro JM; Saucedo JF;
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1127-36. PubMed ID: 22431166
[TBL] [Abstract][Full Text] [Related]
11. Long term follow-up of drug eluting versus bare metal stents in the treatment of saphenous vein graft lesions.
Ybarra LF; Ribeiro HB; Pozetti AH; Campos CA; Esper RB; Lemos PA; Lopes AC; Kalil-Filho R; Ellis SG; Ribeiro EE
Catheter Cardiovasc Interv; 2013 Dec; 82(7):E856-63. PubMed ID: 23239630
[TBL] [Abstract][Full Text] [Related]
12. Early beneficial effects of drug-eluting stents in vein grafts wane during long term follow-up: a case-control study.
Pasceri V; Tarsia G; Niccoli G; Viceconte N; Porto I; Leone AM; Trani C; Speciale G; Lisanti P
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1112-7. PubMed ID: 22422701
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry.
Hougaard M; Thayssen P; Kaltoft A; Tilsted HH; Maeng M; Lassen JF; Thuesen L; Okkels Jensen L
Catheter Cardiovasc Interv; 2014 Jun; 83(7):1035-42. PubMed ID: 24311384
[TBL] [Abstract][Full Text] [Related]
14. Comparison of long-term outcomes of drug-eluting stents and bare metal stents for saphenous vein graft stenosis.
Chakravarty T; Morrissey RP; Wertman B; Naghi J; Chou S; Goykhman P; Doctor N; Mirocha J; Forrester JS; Makkar R
Catheter Cardiovasc Interv; 2012 May; 79(6):903-9. PubMed ID: 21805570
[TBL] [Abstract][Full Text] [Related]
15. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
Brilakis ES; Lichtenwalter C; Abdel-karim AR; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S
JACC Cardiovasc Interv; 2011 Feb; 4(2):176-82. PubMed ID: 21349456
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous Coronary Intervention of Saphenous Vein Graft.
Redfors B; Généreux P; Witzenbichler B; McAndrew T; Diamond J; Huang X; Maehara A; Weisz G; Mehran R; Kirtane AJ; Stone GW
Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28495896
[TBL] [Abstract][Full Text] [Related]
17. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.
Brodie BR; Wilson H; Stuckey T; Nussbaum M; Laurent S; Bradshaw B; Humphrey A; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Simonton CA;
JACC Cardiovasc Interv; 2009 Nov; 2(11):1105-12. PubMed ID: 19926052
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Drug-Eluting Stents With Bare-Metal Stents for PCI of Saphenous Vein Graft Lesions: Systematic Review and Meta-Analysis.
Mosleh W; Gandhi S; Elsiddig M; Schwalm JD; Farkouh ME
J Invasive Cardiol; 2016 Dec; 28(12):E139-E169. PubMed ID: 27845875
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of the Drug-Eluting Stents vs Bare-Metal Stents in Saphenous Vein Graft Angioplasty (DIVA) Trial.
Brilakis ES; Banerjee S; Edson R; Shunk K; Goldman S; Holmes DR; Bhatt DL; Rao SV; Smith MW; Sather M; Colling C; Kar B; Nielsen L; Conner T; Wagner T; Rangan BV; Ventura B; Lu Y; Holodniy M; Shih MC
Clin Cardiol; 2017 Nov; 40(11):946-954. PubMed ID: 28841230
[TBL] [Abstract][Full Text] [Related]
20. Seven-year safety and efficacy of the unrestricted use of drug-eluting stents in saphenous vein bypass grafts.
Nauta ST; Van Mieghem NM; Magro M; Deckers JW; Simsek C; Van Geuns RJ; Van Der Giessen WJ; De Jaegere P; Regar E; Van Domburg RT; Serruys PW
Catheter Cardiovasc Interv; 2012 May; 79(6):912-8. PubMed ID: 21542111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
